Abstract
In the present report we describe the characteristics of 189 antimicrobial-resistant Streptococcus agalactiae isolates from bovine (38 isolates) and human (151 isolates) sources. All the strains were resistant to tetracycline (TET), and 16 (8.5%) were also resistant to erythromycin, corresponding to 23.7% of the TET-resistant bovine isolates and 4.6% of the TET-resistant human isolates. The tet(O), erm(B), and mreA resistance-related genes, as well as the bca and scpB virulence-related genes, were the most frequent among the bovine isolates, while the tet(M), erm(A), mreA, bca, lmb, and scpB genes were the most prevalent among the isolates from humans. Although a few major clusters were observed, pulsed-field gel electrophoresis results revealed a variety of profiles, reflecting the substantial genetic diversity among strains of this species isolated from either humans or bovines.
Streptococcus agalactiae (group B Streptococcus [GBS]) is an important bovine pathogen, especially as a cause of both clinical and subclinical mastitis in dairy cows (23). In humans, GBS has been described as one of the most common agents of invasive infections in neonates, but it also causes invasive and noninvasive infections in adults (29). β-Lactam agents constitute the drugs of choice for the prophylaxis and treatment of GBS infections, since GBS isolates with confirmed resistance to these antimicrobial agents have not been observed to date (23, 29). Erythromycin and other macrolides are the recommended second-line agents and the first alternative in case of allergy to β-lactams. Several studies, however, have documented the emergence and spread of resistance of GBS to macrolides (2, 3, 9, 10), usually in association with resistance to tetracycline.
In streptococci, the most frequent macrolide resistance mechanisms are ribosomal modification by a methylase encoded by an erm gene (37) and drug efflux by a membrane-bound protein encoded by a mef gene (24). The presence of the Erm methylase confers resistance to erythromycin and inducible or constitutive resistance to lincosamines and streptogramin B (the macrolide-lincosamine-streptogramin B [MLSB] phenotype), while the presence of the Mef pump confers resistance to 14- and 15-membered macrolides (M phenotype). An additional efflux mechanism, encoded by the mreA gene, has been described in GBS (8). The linB gene, described in Enterococcus faecium (4), was recently detected in a GBS isolate (10).
Although resistance to tetracycline among GBS isolates is frequently found at high rates and, therefore, tetracycline is no longer indicated for the treatment of GBS infections, tetracycline resistance genes are often found on the same motile unit as the erythromycin resistance genes (33), raising concern about the role of tetracycline-resistant strains in the spread of erythromycin-resistant strains. A variety of tetracycline resistance genes have been described to date, and most of them encode either a protein which pumps tetracycline out of the cell or a ribosomal protein which protects the ribosomes from the action of tetracycline (33).
Different biotypes or ecovars of GBS have been detected when the phenotypic characteristics of isolates recovered from human and bovine sources were compared (13, 19, 22, 26, 38). While several previous studies have also compared the molecular characteristics of strains isolated from different hosts (6, 12, 15, 16, 20, 22, 25), only a few have explored the genetic mechanisms of antimicrobial resistance and the presence of genetic determinants that encode potential virulence factors.
Recently, we have investigated the phenotypic and molecular characteristics of GBS strains obtained from bovine (17) and human (R. S. Duarte et al., unpublished data) clinical specimens in Brazil. Resistance to tetracycline was found among most of the isolates (151 isolates; 90.9%) from human sources and 38 (44.7%) of the bovine isolates, while erythromycin resistance was detected among 10.5% of the bovine isolates and 4.2% of the human isolates. In the present report we describe the characteristics of the macrolide- and/or tetracycline-resistant isolates recovered during these studies and compare the distributions of antimicrobial resistance genes and virulence-related genes among isolates from different sources.
MATERIALS AND METHODS
Bacterial isolates.
A total of 189 antimicrobial-resistant GBS isolates, corresponding to 38 isolates from bovines and 151 from human sources, were included in the present study. The 38 bovine GBS isolates were all recovered from the milk of dairy cows with clinical and subclinical mastitis. The cows belonged to 16 herds distributed in two major states located in the southeast region of Brazil: 32 isolates were from 15 herds located in Minas Gerais State, and 6 isolates were from one herd located in Rio de Janeiro State. Most bovine isolates were recovered during 1999 (15 isolates) and 2000 (12 isolates). The remaining 11 bovine isolates were obtained during the period from 1995 to 1997. The 151 human isolates were obtained from different sources, including 60 strains from genital tract secretions, 57 from urine, 15 from respiratory tract secretions, 7 from skin and superficial wounds, 6 from placenta or umbilical secretions, and 3 from blood; the remaining 3 strains were from other sources (2 from rectal secretions and 1 from a catheter). The isolates from human sources were all recovered during the period from 2000 to 2001 in Rio de Janeiro State. The isolates were preserved as heavy bacterial suspensions in 10% skim milk (Difco Laboratories, Detroit, Mich.) containing 10% glycerol at −20°C. For most tests, GBS strains were grown on Trypticase soy agar (BBL Microbiology Systems, Cockeysville, Md.) supplemented with 5% sheep blood (TSA-SB) at 37°C for 18 to 24 h. The isolates were identified on the basis of conventional morphological and physiological methods and reactivity with Lancefield group B-specific antiserum (18). Serological typing was performed by a coagglutination method with reagents prepared in our laboratory according to the recommendations of Christensen et al. (7). Autoagglutinable isolates were serotyped by the capillary precipitation method (18).
Antimicrobial susceptibility testing.
Susceptibilities to tetracycline and erythromycin were determined by the agar diffusion method according to the guidelines of the National Committee for Clinical Laboratory Standards (27). Macrolide resistance phenotypes were determined by the double-disk test on Mueller-Hinton agar supplemented with 5% sheep blood with erythromycin and clindamycin disks, as described previously (31).
Detection of antimicrobial resistance genes.
The strains were evaluated by single PCR tests for the presence of genetic determinants associated with resistance to erythromycin and resistance to tetracycline. Preparation of DNA extracts was based on a previously described method (15). Briefly, 10 to 20 colonies of a fresh culture on TSA-SB were suspended in 50 μl of distilled water and boiled for 5 min. The sets of primers used for detection of antimicrobial resistance genes are indicated in Table 1. For detection of erythromycin resistance genes, the reaction mixtures, in final volumes of 50 μl, contained MgCl2 [1.5 mM for the mreA gene; 2 mM for the erm(A), erm(B), and linB genes; and 4 mM for the mef(A) gene], deoxynucleoside triphosphates (0.2 mM each), primers (0.5 μM each), Taq DNA polymerase (0.5 U), reaction buffer (10 mM), and 1 μl of DNA extract, which was used as the template. The reaction mixtures for detection of tetracycline resistance genes contained 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 3 mM MgCl2, 0.2 mM each nucleotide, 0.5 mM each primer, 2.5 U of Taq DNA polymerase, and 5 μl of DNA template (36). Conditions for amplification of the erm(A), erm(B), and mef(A) genes were as follows: initial denaturation at 93°C for 3 min, followed by 35 cycles of denaturation at 93°C for 1 min, primer annealing at 52°C for 1 min, and extension at 72°C for 1 min, with a final elongation step at 72°C for 5 min (32, 34). Amplification conditions for detection of the mreA gene were initial denaturation at 95°C for 2 min, followed by 25 cycles at 94°C for 1 min, primer annealing at 53°C for 1 min, and extension at 72°C for 1 min, with a final elongation step at 72°C for 10 min (8). For detection of the linB gene the conditions were initial denaturation at 94°C for 5 min, followed by 35 cycles at 94°C for 45 s, primer annealing at 54°C for 45 s, and extension at 72°C for 1 min, with a final elongation step at 72°C for 5 min (4). Conditions for amplification of tetracycline resistance genes consisted of 35 cycles of 1 min at 95°C, 1 min at 50°C, and 1 min and 30 s at 72°C, followed by a final 5 min at 72°C for tests for all genes except tet(O), for which the annealing temperature was 55°C (36). Amplifications were performed in a GeneAmp PCR System 2400 thermocycler (Perkin-Elmer Applied Biosystems, Branchburg, N.J.). PCR products were resolved by electrophoresis on 1.2% agarose gels in 0.5× TBE buffer (1 mM Tris, 0.01 M EDTA, 1 M boric acid). The gels were stained with ethidium bromide and then visualized and photographed under UV light. The size of each PCR product was estimated by using standard molecular size markers (100-bp ladder; Pharmacia Biotech, Uppsala, Sweden).
TABLE 1.
Target genes and oligonucleotide primers used to amplify antimicrobial resistance genes and virulence-related genes of S. agalactiae isolates
| Gene type and target gene | Forward primer sequence (5′-3′) | Reverse primer sequence (5′-3′) | Amplicon length (bp) | Annealing temp (°C) | Reference |
|---|---|---|---|---|---|
| Erythromycin resistance genes | |||||
| erm(A) | GCA TGA CAT AAA CCT TCA | AGG TTA TAA TGA AAC AGA | 206 | 52 | 32 |
| erm(B) | GAA AAG GTA CTC AAC CAA ATA | AGT AAC GGT ACT TAA ATT GTT TAC | 639 | 52 | 34 |
| mef(A) | AGT ATC ATT AAT CAC TAG TGC | TTC TTC TGG TAC TAA AAG TGG | 348 | 52 | 34 |
| mreA | AGA CAC CTC GTC TAA CCT TCG CTC | TTC AGT TAC TAC CAT GCC ACA GG | 121 | 53 | 8 |
| linB | CCT ACC TAT TGT TTG TGG AA | ATA ACG TTA CTC TCC TAT TC | 944 | 54 | 4 |
| Tetracycline resistance genes | |||||
| tet(K) | TAT TTT GGC TTT GTA TTC TTT CAT | GCT ATA CCT GTT CCC TCT GAT AA | 1,159 | 50 | 36 |
| tet(L) | ATA AAT TGT TTC GGG TCG GTA AT | AAC CAG CCA ACT AAT GAC AAT GAT | 1,077 | 50 | 36 |
| tet(M) | AGT TTT AGC TCA TGT TGA TG | TCC GAC TAT TTA GAC GAC GG | 1,892 | 50 | 36 |
| tet(O) | AGC GTC AAA GGG GAA TCA CTA TCC | CGG CGG GGT TGG CAA ATA | 1,723 | 55 | 36 |
| Virulence-related genes | |||||
| bac | TGT AAA GGA CGA TAG TGT GAA GAC | CAT TTG TGA TTC CCT TTT GC | 530 | 50 | 15 |
| bca | CAG GAG GGG AAA CAA CAG TAC | GTA TCC TTT GAT CCA TCT GGA TAC G | 183 | 50 | 16 |
| lmb | GAC GCA ACA CAC GGC AT | TGA TAG AGC ACT TCC AAA TTT G | 300 | 50 | 15 |
| scpB | ACA ATG GAA GGC TCT ACT GTT C | ACC TGG TGT TTG ACC TGA ACT A | 255 | 50 | 16 |
The following strains were included as positive controls for specific amplification of the different genes investigated: Streptococcus pyogenes CL-5062 [tet(K)], S. agalactiae CL-5957 [tet(L)], S. pyogenes CL-1218 [tet(M)], S. pyogenes CL-2185 [tet(O)], S. pyogenes CL-3760 [erm(A)], Streptococcus pneumoniae (Sp. 398) [erm(B)], E. faecium CL-1727 (linB), and S. pyogenes CL-3870 [mef(A)]. Antimicrobial-susceptible S. agalactiae strains (strains CL-5736 and CL-5953) were used as negative controls.
Detection of virulence-related genes.
PCR was also used to evaluate the strains for the presence of genes encoding surface proteins of GBS potentially associated with virulence. Genomic DNA was prepared as described above, and 5-μl volumes of the supernatants were used for PCRs, as described previously (15). The sets of primers (synthesized by Invitrogen Life Technologies Brazil, São Paulo, Brazil) used for the detection of genes encoding immunoglobulin A-binding β-antigen (bac), α-antigen (bca), laminin-binding surface protein (lmb), and C5a peptidase (scpB) are listed in Table 1. PCR conditions consisted of an initial denaturation step at 94°C for 2 min, followed by 30 cycles of denaturation (94°C, 30 s), primer annealing (50°C, 1 min), and final extension (72°C, 1 min). Electrophoresis and visualization of PCR products were performed as described above.
Analysis of chromosomal DNA restriction profiles by PFGE.
The genetic diversity of the resistant GBS isolates was also evaluated by analysis of the chromosomal DNA restriction profiles after digestion with SmaI and separation of the fragments by pulsed-field gel electrophoresis (PFGE). For that, chromosomal DNA was extracted in agarose plugs and treated with SmaI restriction endonuclease as previously recommended by Teixeira et al. (35). The fragments were separated by PFGE in 1.2% agarose gels in a CHEF-DRIII system (Bio-Rad Laboratories, Hercules, Calif.) with pulse times increasing from 2 to 30 s over 22.5 h at 11°C at a voltage gradient of 6 V/cm. The gels were stained with ethidium bromide and then photographed under UV light. The SmaI restriction profiles were initially compared by visual inspection. Computer-assisted analysis was also performed by using the Molecular Analyst Fingerprinting Plus software (version 1.6) of the Image Analysis System (Bio-Rad). Comparison of the banding patterns was accomplished by the unweighted pair group method with arithmetic averages by using the Dice similarity coefficient.
Statistical analysis.
Epi-Info (Database and Statistics Program for Public Health) software (version 6.04; Centers for Disease Control and Prevention, Atlanta, Ga.) was used to analyze the data on the distributions of the different genes by source by the chi-square test for categorical variables. P values of 0.05 or less were considered statistically significant.
RESULTS AND DISCUSSION
All 189 strains included in this study were resistant to tetracycline, and 8.5% were also resistant to erythromycin, corresponding to 23.7% of the bovine isolates and 4.6% of the human isolates. The distribution of strains resistant to erythromycin and/or tetracycline by origin and serotype of GBS is shown in Fig. 1. In our previous study (17) in which the collection of 38 bovine isolates included in the present work originated, serotype III was the most frequent (66 strains; 77.6%), followed by serotypes II (10 strains; 11.8%), Ia (5 strains; 5.9%), Ib (2 strains; 2.35%), and VI (2 strains; 2.35%). Resistance to tetracycline was found in all the isolates belonging to serotypes Ia, Ib, and VI and among the majority (9 of 10) of serotype II isolates. In contrast, only 18 (27.3%) serotype III strains were resistant to tetracycline. Resistance to erythromycin was observed in 10.5% of the bovine strains that we previously studied; these represented 23.7% of the 38 tetracycline-resistant isolates selected for inclusion in the present study. The nine erythromycin-resistant isolates were obtained from six different herds located in Minas Gerais State. Resistance to erythromycin was predominately associated with serotype II isolates (5 serotype II isolates; 50%) and was also found in 4 (22.2%) serotype III isolates. Tetracycline resistance was found in most (90.9%) of the strains identified in our recent study on GBS isolated from human sources (Duarte et al., unpublished data). The 151 tetracycline-resistant human isolates included in the present study comprised 62 isolates of serotype Ia, 17 isolates of serotype Ib, 40 isolates of serotype II, 21 isolates of serotype III, and 11 isolates of serotype V. Macrolide resistance was found in seven (4.6%) tetracycline-resistant strains of human origin, comprising four isolates belonging to serotype V and three isolates belonging to serotype Ia. These isolates represented 36.4% of the tetracycline-resistant serotype V strains and 4.8% of the tetracycline-resistant serotype Ia strains. All erythromycin-resistant strains of both bovine and human origin were also resistant to tetracycline.
FIG. 1.
Occurrence of resistance to erythromycin (Ery-R) and tetracycline (Tet-R) and distribution of virulence-related genes among S. agalactiae isolates by origin and serotype.
The frequencies of the different genes associated with erythromycin and tetracycline resistance varied according to the origin of the GBS isolates (Table 2). The tet(O) gene was the most frequent determinant among the 38 tetracycline-resistant isolates of bovine origin and was found in 27 strains (71%), followed by tet(M) (16 strains; 42.1%) and tet(L) (3 strains; 7.8%). Seven (18.2%) strains harboring tet(O) also harbored tet(M), while two tet(O)-positive isolates also possessed the tet(L) gene simultaneously. Only one tetracycline-resistant isolate did not harbor any of the tet genes for which tests were conducted. The tet(M) gene was the predominant tet gene among the 151 tetracycline-resistant isolates from humans (139 isolates; 92%), followed by tet(O) (21 isolates; 13.9%) and tet(L) (1 strain; 0.6%). Only one tetracycline-resistant strain of human origin did not harbor any of the tetracycline resistance genes for which tests were conducted, and 10 isolates harbored both the tet(M) and the tet(O) genes. Statistically significant differences (P < 0.001) in the distributions of tet(M) and tet(O) were found between the strains isolated from bovine milk and those isolated from human sources. The tet(K) gene was not detected among GBS isolates of bovine or human origin.
TABLE 2.
Distribution of erythromycin and tetracycline resistance genes among S. agalactiae strains recovered from bovine and human sources in Brazil
| Source | Erythromycin resistance phenotypea | No. (%) of resistant strains harboring resistance genesb
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Erythromycin resistance genes
|
Tetracycline resistance genes
|
||||||||||||
| Total | erm(A) | erm(B) | mreA | erm(A) and erm(B) | Total | tet(L) | tet(M) | tet(O) | tet(M) and tet(O) | tet(L) and tet(M) | tet(L) and tet(O) | ||
| Bovine milk | cMLSB | 9 | 6 (66.6) | 9 (100) | 9 (100) | 6 (66.6) | 38 | 3 (7.8) | 16 (42.1) | 27 (71.0) | 7 (18.2) | 0 | 2 (5.2) |
| Human | cMLSB | 3 | 2 (66.6) | 1 (33.3) | 3 (100) | 0 | 151 | 1 (0.6) | 139 (92.0) | 21 (13.9) | 10 (6.6) | 1 (0.6) | 0 |
| iMLSB | 4 | 4 (100) | 2 (50.0) | 4 (100) | 2 (50.0) | ||||||||
Phenotype M was not detected among isolates obtained from either bovine or human sources. cMLSB, constitutive MLSB resistance phenotype; iMLSB, inducible MLSB resistance phenotype.
The mef(A), linB, and tet(K) genes were not detected among the antimicrobial-resistant S. agalactiae isolates.
All nine erythromycin-resistant isolates of bovine origin presented the constitutive MLSB phenotype, which indicates concomitant constitutive resistance to clindamycin. They all had the erm(B) and the mreA genes, and six of them also had the erm(A) gene. All erythromycin-resistant GBS isolates of bovine origin carried the tet(O) gene; two of them also carried the tet(M) gene simultaneously and one carried the tet(L) gene simultaneously. Most of the seven human GBS strains (four isolates) had the inducible MLSB phenotype and harbored the erm(A) gene, and two of them also harbored the erm(B) genetic determinant. Three human strains had the constitutive MLSB phenotype and were found to contain the erm(A) gene (two strains) or the erm(B) gene (one strain). The mreA gene was found in all erythromycin-resistant strains as well as in all erythromycin-susceptible strains. This finding confirms previous evidence of the ubiquitous presence of this gene in resistant and susceptible isolates (10, 28), supporting the hypothesis that the mreA gene may not be directly related to erythromycin resistance. The absence of the mef(A) and linB genes among Brazilian GBS isolates confirms previous evidence indicating that these genes are not frequently associated with MLSB resistance in S. agalactiae isolates (2, 10, 28). Resistance to tetracycline among the erythromycin-resistant isolates recovered from human sources was due to the presence of the tet(M) gene. Several virulence profiles were found among erythromycin-resistant isolates. Table 3 shows the characteristics of GBS strains simultaneously resistant to erythromycin and tetracycline.
TABLE 3.
Phenotypic and genotypic characteristics of macrolide-resistant S. agalactiae isolates from bovine and human sources in Brazil
| Isolate origin and strain | Source | Yr of isolation | Serotype | Macrolide resistance phenotypea | Amplification reaction resultb
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macrolide resistance gene
|
Tetracycline resistance genes
|
Virulence-related genesb
|
|||||||||||
| erm(A) | erm(B) | mreA | tet(L) | tet(M) | tet(O) | bca | lmb | scpB | |||||
| Bovine isolates | |||||||||||||
| CL-5592 | Bovine milk | 1995 | II | cMLSB | + | + | + | − | − | + | + | − | − |
| CL-5595 | Bovine milk | 1996 | III | cMLSB | + | + | + | + | − | + | + | − | + |
| CL-5599 | Bovine milk | 1997 | II | cMLSB | + | + | + | − | − | + | + | − | + |
| CL-5600 | Bovine milk | 1997 | III | cMLSB | + | + | + | − | − | + | + | − | − |
| CL-5651 | Bovine milk | 1999 | II | cMLSB | + | + | + | − | + | + | + | + | + |
| CL-5652 | Bovine milk | 1999 | II | cMLSB | + | + | + | − | − | + | + | − | + |
| CL-5654 | Bovine milk | 1999 | II | cMLSB | − | + | + | − | + | + | + | − | − |
| CL-5675 | Bovine milk | 2000 | III | cMLSB | − | + | + | − | − | + | + | − | + |
| CL-5676 | Bovine milk | 2000 | III | cMLSB | − | + | + | − | − | + | + | − | + |
| Human isolates | |||||||||||||
| CL-5570 | Wound | 2000 | Ia | iMLSB | + | − | + | − | + | − | − | + | + |
| CL-5784 | Urine | 2000 | V | iMLSB | + | − | + | − | + | − | − | + | + |
| CL-5812 | Urine | 2000 | V | cMLSB | − | + | + | − | + | − | − | + | + |
| CL-5823 | FGT sec.c | 2000 | V | cMLSB | + | − | + | − | + | − | + | + | + |
| CL-5886 | Urine | 2000 | V | iMLSB | + | + | + | − | + | − | − | + | + |
| CL-5965 | FGT sec. | 2001 | Ia | iMLSB | + | + | + | − | + | − | + | + | + |
| CL-6071 | Urine | 2001 | Ia | cMLSB | + | − | + | − | + | − | + | + | + |
cMLSB, constitutive MLSB resistance phenotype; iMLSB, inducible MLSB resistance phenotype.
+, positive amplification reaction; −, negative amplification reaction.
FGT sec., female genital tract secretion.
Most of the studies on the mechanisms and genetic determinants of erythromycin and tetracycline resistance in GBS usually focus on the macrolide resistance of isolates recovered from human sources, due to the clinical importance of these antimicrobial agents (1, 2, 3, 5, 9, 10, 11, 14, 21, 28, 30). However, although tetracycline is no longer used for the treatment of streptococcal infections, studies are necessary to elucidate whether high rates of tetracycline resistance constitute a potential risk factor for the acquisition of other resistance genes, since elements that transfer tetracycline resistance genes can also carry genes encoding resistance to macrolides, lincosamides, and chloramphenicol (9, 33).
As previously reported for strains isolated in other countries (1, 2, 9, 10, 28), constitutive and inducible MLSB phenotypes predominate among human isolates, although differences in the frequencies of these phenotypes were noted. The M phenotype was not detected in the present investigation, but its occurrence has been reported among human GBS isolates at low rates (2, 9, 10, 21, 28). Overall, the distribution of the different antimicrobial resistance genetic determinants in human GBS isolates was also similar to those described in previous reports (1, 2, 9, 10, 28). As expected, the erm(A) and the erm(B) genes were the most prevalent among erythromycin-resistant GBS strains, as were the tet(M) and the tet(O) genes among the tetracycline-resistant isolates from human sources. On the other hand, studies on erythromycin resistance in GBS isolates from other hosts are lacking, and only a few have investigated the distribution of tet genetic determinants among tetracycline-resistant GBS strains obtained from animal sources. Our results showed that erm(B) and tet(O) were the most frequent genes associated with erythromycin and tetracycline resistance, respectively, in GBS isolates from bovines. The higher frequency of the tet(O) and the tet(M) genes among GBS strains recovered from dairy cows was described previously (5, 30).
The virulence genes bac, bca, lmb, and scpB were detected in 0 (0%), 30 (78.9%), 6 (15.8%), and 25 (65.8%) of the tetracycline-resistant GBS strains from bovines, respectively, and in 13 (7.3%), 116 (76.8%), 147 (97.3%), and 146 (96.7%) of the tetracycline-resistant isolates from human sources, respectively. The distribution of virulence genes among antimicrobial-resistant GBS strains of different serotypes by origin is shown in Fig. 1. Table 4 shows the frequencies of the different virulence profiles among antimicrobial-resistant GBS strains by origin. The majority of the tetracycline-resistant GBS strains from human sources (146 isolates; 96.7%) had both the lmb and scpB genes simultaneously, and a large proportion (101 isolates; 66.9%) had the bca, lmb, and scpB genes simultaneously. The presence of these three genes characterized the prevalent virulence profile among human isolates. Among the bovine isolates resistant to tetracycline, the most frequent profile consisted of simultaneous carriage of both the bca and the scpB genes and was found in 17 isolates (44.7%). All six lmb-positive bovine strains were also scpB positive. The distinct distribution of the virulence-related genes investigated among the GBS isolates recovered from human and bovine sources indicates that different virulence traits may be involved in the pathogenesis of infections caused by this microorganism in these hosts and that diverse evolutionary lineages of GBS are associated with different hosts. None of the erythromycin-resistant isolates had the mef(A), linB, or bac gene.
TABLE 4.
Occurrence of different profiles of virulence-related genetic determinants among antimicrobial-resistant S. agalactiae strains recovered from bovine and human sources in Brazil
| Profile | Virulence gene profilea | No. (%) of isolates
|
|
|---|---|---|---|
| Bovine isolates (total n = 38) | Human isolates (total n = 151) | ||
| A | bac−bca+lmb+scpB+ | 5 (13.1) | 101 (66.9) |
| B | bac−bca−lmb+scpB+ | 1 (2.6) | 34 (22.5) |
| C | bac−bca−lmb−scpB+ | 2 (5.3) | 0 (0) |
| D | bac−bca−lmb−scpB− | 5 (13.1) | 1 (0.7) |
| E | bac−bca+lmb+scpB− | 0 (0) | 1 (0.7) |
| F | bac−bca+lmb−scpB+ | 17 (44.7) | 0 (0) |
| G | bac−bca+lmb−scpB− | 8 (21.0) | 3 (2.0) |
| H | bac+bca+lmb+scpB+ | 0 (0) | 11 (7.3) |
−, negative for the gene; +, positive for the gene.
Although a few major clusters were observed, PFGE revealed a variety of profiles (data not shown), reflecting the substantial genetic diversity among antimicrobial-resistant GBS strains isolated from either humans or bovines. When the PFGE profiles of erythromycin-resistant isolates were compared separately, two major clusters were observed, corresponding to most of the isolates of bovine and human origin, respectively (Fig. 2). Clustering was particularly observed among human isolates of serotype V resistant to erythromycin. We conclude that resistance to erythromycin and tetracycline among S. agalactiae strains may occur predominantly due to the multiclonal spread of resistance genes instead of being related to the epidemic dissemination of a few clones.
FIG. 2.
Dendrogram resulting from a computer-assisted analysis of the PFGE profiles of SmaI-digested DNA of erythromycin-resistant Streptococcus agalactiae strains isolated from bovine and human sources in Brazil.
This study is the first to correlate the distribution of the genetic mechanisms of macrolide and tetracycline resistance as well as the occurrence of genetic determinants encoding for surface proteins potentially associated with virulence among the different serotypes of S. agalactiae from bovines and humans in Brazil. Among the human isolates, tetracycline resistance was associated with most of the serotypes identified and was predominantly due to the presence of the tet(M) gene. This resistance marker was also found in a large proportion of bovine isolates, predominantly due to the presence of the tet(O) gene, and in association with several serotypes. Differences in the frequencies of genes coding for potential virulence factors were also noted among bovine and human isolates, reinforcing the concept that distinct GBS populations circulate among bovine and human hosts. While the knowledge of the most prevalent serotypes and other molecular characteristics of GBS isolates from a given geographical area is essential to trace the epidemiological course of infections, surveillance of the genetic backgrounds of antimicrobial-resistant GBS strains circulating in different hosts and regions is relevant to guiding the design of more appropriate procedures for infection control and prevention.
Acknowledgments
This study was supported in part by Conselho Nacional de Desenvolvimento Científico e Tecnológico, Financiadora de Estudos e Projetos, Fundação Universitária José Bonifácio, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro, and Ministério da Ciência e Tecnologia (MCT/PRONEX) of Brazil.
Typing antisera were kindly provided by R. R. Facklam, Streptococcus Laboratory, Centers for Disease Control and Prevention. We thank Carlos Ausberto B. de Souza and Filomena Soares Pereira da Rocha for technical assistance.
REFERENCES
- 1.Aracil, B., M. Miñambres, J. Oteo, M. de la Rosa, J. L. Gómez-Garcés, and J. I. Alós. 2002. Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin. Microbiol. Infect. 8:745-748. [DOI] [PubMed] [Google Scholar]
- 2.Betriu, C., E. Culebras, I. Rodríguez-Avial, M. Gómez, B. A. Sánchez, and J. J. Picazo. 2004. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob. Agents Chemother. 48:323-325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bingen, E., C. Doit, P. Bidet, N. Brahimi, and D. Deforche. 2004. Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections. Antimicrob. Agents Chemother. 48:677-680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bozdogan, B., L. Berrezouga, M.-S. Kuo, D. A. Yurek, K. A. Farley, B. J. Stockman, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43:925-929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Brown, M. B., and M. C. Roberts. 1991. Tetracycline resistance determinants in streptococcal species isolated from the bovine mammary gland. Vet. Microbiol. 29:173-180. [DOI] [PubMed] [Google Scholar]
- 6.Chatellier, S., C. Ramanantsoa, P. Harriau, K. Rolland, A. Rosenau, and R. Quentin. 1997. Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis. J. Clin. Microbiol. 35:2573-2579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Christensen, P., G. Kahlmeter, S. Jonsson, and G. Kronvall. 1973. New method for the serological grouping of streptococci with specific antibodies adsorbed to protein A-containing staphylococci. Infect. Immun. 7:881-885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Clancy, J., F. Dib-Hajj, J. W. Petitpas, and W. Yuan. 1997. Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob. Agents Chemother. 41:2719-2723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Culebras, E., I. Rodriguez-Avial, C. Betriu, M. Redondo, and J. J. Picazo. 2002. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob. Agents Chemother. 46:1574-1576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.de Azavedo, J., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.de Mouy, D., J.-D. Cavallo, R. Leclercq, R. Fabre, and The Aforcopi-Bio Network. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob. Agents Chemother. 45:2400-2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Denning, D. W., C. J. Baker, N. J. Troup, and L. S. Tompkins. 1989. Restriction endonuclease analysis of human and bovine group B streptococci for epidemiologic study. J. Clin. Microbiol. 27:1352-1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Devriese, L. A. 1991. Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes. J. Appl. Bacteriol. 71:478-483. [DOI] [PubMed] [Google Scholar]
- 14.Diekema, D. J., J. I. Andrews, H. Huynh, P. R. Rhomberg, S. R. Doktor, J. Beyer, V. D. Shortridge, R. K. Flamm, R. N. Jones, and M. A. Pfaller. 2003. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J. Clin. Microbiol. 41:2659-2661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dmitriev, A., E. Shakleina, L. Tkacikova, and A. Totolian. 2002. Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci. Folia Microbiol. 47:291-295. [DOI] [PubMed] [Google Scholar]
- 16.Dmitriev, A., L. Tkacikova, A. Suvorov, M. Kantikova, I. Mikula, and A. Totolian. 1999. Comparative genetic study of group B streptococcal strains of human and bovine origin. Folia Microbiol. 44:449-453. [DOI] [PubMed] [Google Scholar]
- 17.Duarte, R. S., O. P. Miranda, B. C. Bellei, M. A. V. P. Brito, and L. M. Teixeira. 2004. Phenotypic and molecular characteristics of Streptococcus agalactiae isolates recovered from milk of dairy cows in Brazil. J. Clin. Microbiol. 42:4214-4222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Facklam, R. R., and J. A. Washington II. 1991. Streptococcus and related catalase-negative gram-positive cocci, p. 238-257. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
- 19.Finch, L. A., and D. R. Martin. 1984. Human and bovine group B streptococci: two distinct populations. J. Appl. Bacteriol. 57:273-278. [DOI] [PubMed] [Google Scholar]
- 20.Fraken, C., G. Haase, C. Brandt, J. Weber-Heynemann, S. Martin, C. Lämmler, A. Podbielski, R. Lütticken, and B. Spellerberg. 2001. Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb. Mol. Microbiol. 41:925-935. [DOI] [PubMed] [Google Scholar]
- 21.Hsueh, P.-R., L.-J. Teng, L.-N. Lee, S.-W. Ho, P.-C. Yang, and K.-T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205-3208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jensen, N. E., and F. M. Aarestrup. 1996. Epidemiological aspects of group B streptococci of bovine and human origin. Epidemiol. Infect. 117:417-422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Keefe, G. P. 1997. Streptococcus agalactiae mastitis: a review. Can. Vet. J. 38:429-437. [PMC free article] [PubMed] [Google Scholar]
- 24.Luna, V. A., P. Coates, E. A. Eady, J. H. Cove, T. T. Nguyen, and M. C. Roberts. 1999. A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:19-25. [DOI] [PubMed] [Google Scholar]
- 25.Martinez, G., J. Harel, R. Higgins, S. Lacouture, D. Daignault, and M. Gottschalk. 2000. Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis. J. Clin. Microbiol. 38:71-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mosabi, J. M., S. M. Arimi, and E. K. Kang'ethe. 1997. Isolation and characterization of group B streptococci from human and bovine sources within and around Nairobi. Epidemiol. Infect. 118:215-220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility tests; approved standard, 7th ed. M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
- 28.Portillo, A., M. Lantero, I. Olarte, F. Ruiz-Larrea, and C. Torres. 2001. MLS resistance phenotypes and mechanisms in β-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain. J. Antimicrob. Chemother. 47:113-124. [DOI] [PubMed] [Google Scholar]
- 29.Schuchat, A. 2001. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin. Infect. Dis. 33:751-756. [DOI] [PubMed] [Google Scholar]
- 30.Schwarz, S., I. W. T. Wibawan, and C. H. Lämmler. 1994. Distribution of genes conferring combined resistance to tetracycline and minocycline among group B streptococcal isolates from humans and various animals. Zentbl. Bakteriol. Parasitenkd. Infektkrankh. Hyg. Abt. 1 Orig. 281:526-533. [DOI] [PubMed] [Google Scholar]
- 31.Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891. [DOI] [PubMed] [Google Scholar]
- 32.Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Speer, B. S., N. B. Shoemaker, and A. A. Salyers. 1992. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin. Microbiol. Rev. 5:387-399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Teixeira, L. M., M. G. S. Carvalho, V. L. C. Merquior, A. G. Steigerwalt, D. J. Brenner, and R. R. Facklam. 1997. Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J. Clin. Microbiol. 35:2778-2781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Trzcinski, K., B. S. Cooper, W. Hryniewicz, and C. G. Dowson. 2000. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 45:763-770. [DOI] [PubMed] [Google Scholar]
- 37.Weisblum, B. 1985. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression—a review. J. Antimicrob. Chemother. 16(Suppl. A):63-90. [DOI] [PubMed] [Google Scholar]
- 38.Wilkinson, H. W., L. G. Thacker, and R. R. Facklam. 1973. Nonhemolytic group B streptococci of human, bovine and ichthyic origin. Infect. Immun. 7:496-498. [DOI] [PMC free article] [PubMed] [Google Scholar]